The U.S. Department of State today issued a Reconsider Travel Advisory for the People’s Republic of China (PRC) and the Hong Kong Special Administrative Region (SAR) due to COVID-19 health risks and local laws.
With the Winter Olympics and Paralympics 2022 scheduled to start in early February, this State Department Advisory presents various challenges for international travelers.
Visiting China Comes With COVID-19 Risks
Visiting China Comes With Risks
The U.S. Department of State today issued a Reconsider Travel Advisory for the People’s Republic of China (PRC) and the Hong Kong Special Administrative Region (SAR) due to arbitrary enforcement of local laws.
With the Winter Olympics and Paralympics 2022 scheduled to start in early February, this State Department Advisory presents various challenges for international travelers.
BNT162b2 Vaccine Effective Against Severe COVID-19 in Adolescents
Two doses highly effective against COVID-19-related hospitalization and critical illness for those aged 12 to 18 years
COVID-19 Restrictions Eased in England
As of Jan. 27, COVID-19 passes will no longer be needed to enter large-scale events, use of face masks in public schools will no longer be required
Biden Plans to Send 400 Million N95 Masks to Americans for Free
Move follows updated mask guidance issued by the CDC late last week
WHO Says Worst of Pandemic Could Ease This Year if Vaccine Inequities Erased
Fewer than 10 percent of people in lower-income countries have received one dose of COVID-19 vaccine
Cardiac Outcomes Good for Children With COVID-19-Related MIS-C
All deformation parameters on echocardiogram recovered within first week, including LV global longitudinal strain, peak left atrial strain
AI Model May Predict COVID-19 Outcomes for Critically Ill
Machine learning model incorporates data from 14 proteins derived from a single blood sample to predict survival in patients with COVID-19
Racial, Ethnic Disparities Seen in mAb Treatment for COVID-19
Monoclonal antibody treatment used infrequently among all racial, ethnic groups; Hispanics received mAbs less often than non-Hispanics
Adding a P2Y12 Inhibitor Does Not Improve Outcomes in COVID-19
Adding a P2Y12 inhibitor to a therapeutic dose of heparin does not improve outcomes among non-critically ill patients hospitalized for COVID-19